YXJ-13842-47072 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-05-04
Dose 1 — Pfizer-BioNTech
2021-08-23
Dose 2 — Pfizer-BioNTech
2021-08-24
Registered in v-safe
2021-08-25
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Headache, Muscle or body aches

Adult check-in
2021-08-27
Survey response — days 1–6 daily, dose 2
MedDRA: Injection site bruising — Feeling: Fair · Headache

Free text: Arm bruised at injection site

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-08-28
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Headache · Be unable to do your normal daily activities

Adult check-in
2021-09-01
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-09-08
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-09-13
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-09-20
Survey response — day 28, dose 2
MedDRA: Abdominal pain — Feeling: Fair

Free text: Cramping in abdomen

MedDRA releases: 2024-11 · check-in free text available
2021-09-29
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-10-06
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-11-22
Survey response — 3 months, dose 2
MedDRA: Menstruation irregular, Migraine, Unevaluable event — Feeling: Good · Be unable to do your normal daily activities

Free text: Very hormonal and 2 weeks late for period. Also had a migraine for 4 days

MedDRA releases: 2024-11 · check-in free text available
2022-02-21
Health check-in — 6 months, dose 2
Feeling: Fair

Adult check-in
2022-08-23
Survey response — 12 months, dose 2
MedDRA: Abortion spontaneous, Foetal vascular malperfusion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Placental blood clots that led to miscarriage at 17 weeks

MedDRA releases: 2024-11 · check-in free text available
2022-08-23
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-08-24
Call successful
Participant prefers to complete VAERS report online

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-05-04	Pfizer-BioNTech	No
2	2021-08-23	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-08-23	Successful 2022-08-24	Participant prefers to complete VAERS report online

Free text

Release 9 — days 1–6 daily, dose 2

2021-08-27

Systemic reaction (other): Arm bruised at injection site

Release 9 — day 28, dose 2

2021-09-20

Symptoms: Cramping in abdomen

Release 10 — 3 months, dose 2

2021-11-22

Symptoms: Very hormonal and 2 weeks late for period. Also had a migraine for 4 days

Release 12 — 12 months, dose 2

2022-08-23

Symptoms: Placental blood clots that led to miscarriage at 17 weeks

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Abdominal pain	·	·	✓
SD	Abortion spontaneous	·	·	✓
SD	Foetal vascular malperfusion	·	·	✓
SD	Menstruation irregular	·	·	✓
SD	Migraine	·	·	✓
SD	Unevaluable event	·	·	✓
SRO	Injection site bruising	✓	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release